Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs

European Journal of Pharmacology

Volumn 412, Issue 1, 2001, Pages 101-108

  Rosenstock, Moti ^a   Danon, Abraham ^a   Rubin, Mazal ^a   Rimon, Gilad ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Aspirin; DuP 697; Ibuprofen; Indomethacin; Naproxen; NS 398; Prostaglandin H synthase 1; Prostaglandin H synthase 2; Seminal vesicle microsome, ram

Indexed keywords

5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; ACETYLSALICYLIC ACID; ARACHIDONIC ACID; IBUPROFEN; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; BOVIDS; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; SEMINAL VESICLE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; ASPIRIN; CATTLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; IBUPROFEN; INDOMETHACIN; ISOENZYMES; MALE; MICROSOMES; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SEMINAL VESICLES; SULFONAMIDES; THIOPHENES;

EID: 0035910355     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00931-6     Document Type: Article

References (22)

1. Rofecoxib: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profile
2. Hydroperoxide dependence and cooperative cyclooxygenase kinetics in prostaglandin H synthase-1 and -2
3. Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase
4. Anti-inflammatory and safety profile of DuP-697, a novel orally effective prostaglandin synthesis inhibitor
5. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors
6. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells
7. Cyclo-oxygenase isoenzymes
8. Kinetics of the interaction of nonsteroidal antiinflammatory drugs with prostaglandin endoperoxide synthase-1 studied by limited proteolysis
9. Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents
10. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
11. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
12. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
13. Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis
14. Prostaglandin endoperoxide synthase-1 and -2
15. 2 synthase-1
16. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor
17. Prostaglandin H synthase: Protein synthesis-independent regulation in bovine aortic endothelial cells
18. PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity
19. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2
20. Differential allosteric regulation of prostaglandin H synthase 1 and 2 by arachidonic acid
21. Bromoacetamido analogs of indomethacin and mefenamic acid as affinity-labeling agents and mechanistic probes for prostaglandin H2 synthase
22. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs